1.Recent progress in 2-haloacid dehalogenases.
Yayue WANG ; Song XUE ; Qingfeng ZHOU ; Dongli PEI
Chinese Journal of Biotechnology 2020;36(5):868-878
2-Haloacid dehalogenases (EC 3.8.1.X) catalyze the hydrolytic dehalogenation of 2-haloacids, releasing halogen ions and producing corresponding 2-hydroxyacids. The enzymes not only degrade xenobiotic halogenated pollutants, but also show wide substrate profile and astonishing efficiency for enantiomer resolution, making them valuable in environmental protection and the green synthesis of optically pure chiral compounds. A variety of 2-haloacid dehalogenases have been biochemically characterized so far. Further studies have been made in protein crystal structures and catalytic mechanisms. Here, we review the recent progresses of 2-haloacid dehalogenases in their source, protein structures, reaction mechanisms, catalytic properties and application. We also suggest further research directions for 2-haloacid dehalogenase.
Catalysis
;
Halogenation
;
Hydrolases
;
chemistry
;
metabolism
;
Hydrolysis
;
Research
;
trends
;
Substrate Specificity
2. Mononuclear cells of umbilical cord blood differentiation to granulocyte cell in vitro
Lin CHEN ; Xiaoyan XIE ; Jiqin NIE ; Dongli CHEN ; Anping HUANG ; Fang FANG ; Mingyi QU ; Xue NAN ; Lijuan HE ; Zeng FAN ; Wen YUE ; Xuetao PEI
Chinese Journal of Hematology 2017;38(6):532-536
Objective:
To explore an optimal method for granulocyte cell production from umbilical cord blood mononuclear cells.
Methods:
Erythrocytes were precipitated by hydroxyethyl starch. Mononuclear cells were isolated through Ficoll density gradient centrifugation. Different media, additives and cultivation model were chosen for granulocyte induction. Cell morphology was observed by microscopy, and cell phenotype was detected by flow cytometry. The CD18 expression of granulocytes was tested by immunofluorescence assay, and phagocytosis test was executed as well.
Results:
Compared to fetal bovine serum (FBS) treatment group, cell viability, counts and differentiation rate of granulocytes induced by X-VIVOTM 15 combined with TPO, SCF, G-CSF but without FBS were superior. And X-VIVOTM15 medium was better than SCGM medium at effectiveness and cost. Using two-stage mode of hematopoietic stem cell expansion followed by granulocyte induction with X-VIVOTM15 combining TPO, SCF and G-CSF, cell proliferation was nearly 132 times at day 21. Flow cytometry showed that the differentiation was lagged in 2-stage mode than in direct induction mode, CD15 expression was (69.60± 1.06) %